nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—UGT2B7—Epirubicin—uterine cancer	0.338	0.427	CbGbCtD
Silodosin—ABCB1—Progesterone—uterine cancer	0.101	0.127	CbGbCtD
Silodosin—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0913	0.115	CbGbCtD
Silodosin—ABCB1—Dactinomycin—uterine cancer	0.0801	0.101	CbGbCtD
Silodosin—CYP3A4—Progesterone—uterine cancer	0.0605	0.0763	CbGbCtD
Silodosin—ABCB1—Etoposide—uterine cancer	0.0452	0.057	CbGbCtD
Silodosin—ABCB1—Doxorubicin—uterine cancer	0.0308	0.0389	CbGbCtD
Silodosin—CYP3A4—Etoposide—uterine cancer	0.0271	0.0342	CbGbCtD
Silodosin—CYP3A4—Doxorubicin—uterine cancer	0.0185	0.0233	CbGbCtD
Silodosin—Swollen tongue—Progesterone—uterine cancer	0.0133	0.0663	CcSEcCtD
Silodosin—Swollen tongue—Etoposide—uterine cancer	0.00681	0.0339	CcSEcCtD
Silodosin—Hepatic function abnormal—Progesterone—uterine cancer	0.00325	0.0162	CcSEcCtD
Silodosin—Vascular purpura—Progesterone—uterine cancer	0.00317	0.0158	CcSEcCtD
Silodosin—Nasal congestion—Progesterone—uterine cancer	0.00312	0.0155	CcSEcCtD
Silodosin—Libido decreased—Progesterone—uterine cancer	0.00306	0.0152	CcSEcCtD
Silodosin—Purpura—Progesterone—uterine cancer	0.00295	0.0147	CcSEcCtD
Silodosin—Hepatic function abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00294	0.0147	CcSEcCtD
Silodosin—Disturbance in sexual arousal—Progesterone—uterine cancer	0.00282	0.014	CcSEcCtD
Silodosin—Libido decreased—Medroxyprogesterone Acetate—uterine cancer	0.00277	0.0138	CcSEcCtD
Silodosin—Purpura—Medroxyprogesterone Acetate—uterine cancer	0.00267	0.0133	CcSEcCtD
Silodosin—Liver function test abnormal—Progesterone—uterine cancer	0.00262	0.0131	CcSEcCtD
Silodosin—Breast disorder—Progesterone—uterine cancer	0.00257	0.0128	CcSEcCtD
Silodosin—Disturbance in sexual arousal—Medroxyprogesterone Acetate—uterine cancer	0.00255	0.0127	CcSEcCtD
Silodosin—Nasopharyngitis—Progesterone—uterine cancer	0.00254	0.0126	CcSEcCtD
Silodosin—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00235	0.0117	CcSEcCtD
Silodosin—Breast disorder—Medroxyprogesterone Acetate—uterine cancer	0.00232	0.0116	CcSEcCtD
Silodosin—Nasopharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.0023	0.0115	CcSEcCtD
Silodosin—Jaundice—Progesterone—uterine cancer	0.00213	0.0106	CcSEcCtD
Silodosin—Hepatobiliary disease—Progesterone—uterine cancer	0.00207	0.0103	CcSEcCtD
Silodosin—Sinusitis—Progesterone—uterine cancer	0.00205	0.0102	CcSEcCtD
Silodosin—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00193	0.00962	CcSEcCtD
Silodosin—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.00187	0.00934	CcSEcCtD
Silodosin—Sinusitis—Medroxyprogesterone Acetate—uterine cancer	0.00186	0.00926	CcSEcCtD
Silodosin—Liver function test abnormal—Dactinomycin—uterine cancer	0.00185	0.00923	CcSEcCtD
Silodosin—Cardiac disorder—Progesterone—uterine cancer	0.00182	0.00908	CcSEcCtD
Silodosin—Angiopathy—Progesterone—uterine cancer	0.00178	0.00887	CcSEcCtD
Silodosin—Immune system disorder—Progesterone—uterine cancer	0.00177	0.00883	CcSEcCtD
Silodosin—Mediastinal disorder—Progesterone—uterine cancer	0.00177	0.00881	CcSEcCtD
Silodosin—Mental disorder—Progesterone—uterine cancer	0.00172	0.00857	CcSEcCtD
Silodosin—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.00823	CcSEcCtD
Silodosin—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00161	0.00804	CcSEcCtD
Silodosin—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00161	0.008	CcSEcCtD
Silodosin—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.00799	CcSEcCtD
Silodosin—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00156	0.00776	CcSEcCtD
Silodosin—Syncope—Progesterone—uterine cancer	0.00153	0.00764	CcSEcCtD
Silodosin—Palpitations—Progesterone—uterine cancer	0.00151	0.00752	CcSEcCtD
Silodosin—Loss of consciousness—Progesterone—uterine cancer	0.0015	0.00748	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00145	0.0072	CcSEcCtD
Silodosin—Dry mouth—Progesterone—uterine cancer	0.00142	0.00709	CcSEcCtD
Silodosin—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.00692	CcSEcCtD
Silodosin—Shock—Progesterone—uterine cancer	0.00137	0.00684	CcSEcCtD
Silodosin—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.00682	CcSEcCtD
Silodosin—Nervous system disorder—Progesterone—uterine cancer	0.00137	0.00681	CcSEcCtD
Silodosin—Tachycardia—Progesterone—uterine cancer	0.00136	0.00678	CcSEcCtD
Silodosin—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00678	CcSEcCtD
Silodosin—Skin disorder—Progesterone—uterine cancer	0.00136	0.00675	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00652	CcSEcCtD
Silodosin—Hypotension—Progesterone—uterine cancer	0.0013	0.00649	CcSEcCtD
Silodosin—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.00642	CcSEcCtD
Silodosin—Insomnia—Progesterone—uterine cancer	0.00126	0.00628	CcSEcCtD
Silodosin—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00619	CcSEcCtD
Silodosin—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00617	CcSEcCtD
Silodosin—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00615	CcSEcCtD
Silodosin—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00612	CcSEcCtD
Silodosin—Gastrointestinal disorder—Progesterone—uterine cancer	0.0012	0.006	CcSEcCtD
Silodosin—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00588	CcSEcCtD
Silodosin—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00569	CcSEcCtD
Silodosin—Gastrointestinal pain—Progesterone—uterine cancer	0.00114	0.00568	CcSEcCtD
Silodosin—Urticaria—Progesterone—uterine cancer	0.00111	0.00552	CcSEcCtD
Silodosin—Abdominal pain—Progesterone—uterine cancer	0.0011	0.00549	CcSEcCtD
Silodosin—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00544	CcSEcCtD
Silodosin—Jaundice—Etoposide—uterine cancer	0.00109	0.00543	CcSEcCtD
Silodosin—Hepatobiliary disease—Etoposide—uterine cancer	0.00106	0.00527	CcSEcCtD
Silodosin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00515	CcSEcCtD
Silodosin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.001	0.005	CcSEcCtD
Silodosin—Asthenia—Progesterone—uterine cancer	0.001	0.00499	CcSEcCtD
Silodosin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.001	0.00498	CcSEcCtD
Silodosin—Pruritus—Progesterone—uterine cancer	0.000987	0.00492	CcSEcCtD
Silodosin—Diarrhoea—Progesterone—uterine cancer	0.000955	0.00475	CcSEcCtD
Silodosin—Cardiac disorder—Etoposide—uterine cancer	0.000932	0.00464	CcSEcCtD
Silodosin—Hepatic function abnormal—Epirubicin—uterine cancer	0.000931	0.00464	CcSEcCtD
Silodosin—Dizziness—Progesterone—uterine cancer	0.000923	0.00459	CcSEcCtD
Silodosin—ABCB4—vagina—uterine cancer	0.000921	0.142	CbGeAlD
Silodosin—Angiopathy—Etoposide—uterine cancer	0.000912	0.00454	CcSEcCtD
Silodosin—Vascular purpura—Epirubicin—uterine cancer	0.00091	0.00453	CcSEcCtD
Silodosin—Immune system disorder—Etoposide—uterine cancer	0.000907	0.00452	CcSEcCtD
Silodosin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000907	0.00452	CcSEcCtD
Silodosin—Mediastinal disorder—Etoposide—uterine cancer	0.000905	0.00451	CcSEcCtD
Silodosin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000895	0.00445	CcSEcCtD
Silodosin—Rash—Progesterone—uterine cancer	0.00088	0.00438	CcSEcCtD
Silodosin—Dermatitis—Progesterone—uterine cancer	0.000879	0.00438	CcSEcCtD
Silodosin—Headache—Progesterone—uterine cancer	0.000874	0.00435	CcSEcCtD
Silodosin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000865	0.00431	CcSEcCtD
Silodosin—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000862	0.00429	CcSEcCtD
Silodosin—Purpura—Epirubicin—uterine cancer	0.000845	0.00421	CcSEcCtD
Silodosin—Vascular purpura—Doxorubicin—uterine cancer	0.000842	0.00419	CcSEcCtD
Silodosin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000836	0.00416	CcSEcCtD
Silodosin—Nausea—Progesterone—uterine cancer	0.000829	0.00413	CcSEcCtD
Silodosin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000806	0.00402	CcSEcCtD
Silodosin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000797	0.00397	CcSEcCtD
Silodosin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000796	0.00397	CcSEcCtD
Silodosin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000792	0.00394	CcSEcCtD
Silodosin—Purpura—Doxorubicin—uterine cancer	0.000782	0.00389	CcSEcCtD
Silodosin—Abdominal pain—Dactinomycin—uterine cancer	0.00078	0.00388	CcSEcCtD
Silodosin—Loss of consciousness—Etoposide—uterine cancer	0.000769	0.00383	CcSEcCtD
Silodosin—Liver function test abnormal—Epirubicin—uterine cancer	0.000752	0.00374	CcSEcCtD
Silodosin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000751	0.00374	CcSEcCtD
Silodosin—Orthostatic hypotension—Epirubicin—uterine cancer	0.000744	0.0037	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000739	0.00368	CcSEcCtD
Silodosin—Breast disorder—Epirubicin—uterine cancer	0.000736	0.00366	CcSEcCtD
Silodosin—Nasopharyngitis—Epirubicin—uterine cancer	0.000728	0.00363	CcSEcCtD
Silodosin—Asthenia—Dactinomycin—uterine cancer	0.000708	0.00352	CcSEcCtD
Silodosin—Tachycardia—Etoposide—uterine cancer	0.000697	0.00347	CcSEcCtD
Silodosin—Liver function test abnormal—Doxorubicin—uterine cancer	0.000695	0.00346	CcSEcCtD
Silodosin—Skin disorder—Etoposide—uterine cancer	0.000693	0.00345	CcSEcCtD
Silodosin—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000688	0.00343	CcSEcCtD
Silodosin—Breast disorder—Doxorubicin—uterine cancer	0.000681	0.00339	CcSEcCtD
Silodosin—Diarrhoea—Dactinomycin—uterine cancer	0.000675	0.00336	CcSEcCtD
Silodosin—Nasopharyngitis—Doxorubicin—uterine cancer	0.000674	0.00335	CcSEcCtD
Silodosin—Hypotension—Etoposide—uterine cancer	0.000667	0.00332	CcSEcCtD
Silodosin—UGT2B7—renal system—uterine cancer	0.000651	0.1	CbGeAlD
Silodosin—Rash—Dactinomycin—uterine cancer	0.000622	0.0031	CcSEcCtD
Silodosin—Gastrointestinal disorder—Etoposide—uterine cancer	0.000616	0.00307	CcSEcCtD
Silodosin—Jaundice—Epirubicin—uterine cancer	0.000611	0.00305	CcSEcCtD
Silodosin—ABCB4—lymph node—uterine cancer	0.000596	0.0915	CbGeAlD
Silodosin—Hepatobiliary disease—Epirubicin—uterine cancer	0.000593	0.00295	CcSEcCtD
Silodosin—Sinusitis—Epirubicin—uterine cancer	0.000589	0.00293	CcSEcCtD
Silodosin—Nausea—Dactinomycin—uterine cancer	0.000586	0.00292	CcSEcCtD
Silodosin—Gastrointestinal pain—Etoposide—uterine cancer	0.000584	0.00291	CcSEcCtD
Silodosin—Urticaria—Etoposide—uterine cancer	0.000567	0.00282	CcSEcCtD
Silodosin—Jaundice—Doxorubicin—uterine cancer	0.000566	0.00282	CcSEcCtD
Silodosin—Abdominal pain—Etoposide—uterine cancer	0.000564	0.00281	CcSEcCtD
Silodosin—ADRA1D—epithelium—uterine cancer	0.000556	0.0855	CbGeAlD
Silodosin—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000549	0.00273	CcSEcCtD
Silodosin—Sinusitis—Doxorubicin—uterine cancer	0.000545	0.00271	CcSEcCtD
Silodosin—ADRA1B—renal system—uterine cancer	0.000528	0.0811	CbGeAlD
Silodosin—Cardiac disorder—Epirubicin—uterine cancer	0.000523	0.0026	CcSEcCtD
Silodosin—UGT2B7—female reproductive system—uterine cancer	0.000521	0.0801	CbGeAlD
Silodosin—Asthenia—Etoposide—uterine cancer	0.000512	0.00255	CcSEcCtD
Silodosin—Angiopathy—Epirubicin—uterine cancer	0.000511	0.00254	CcSEcCtD
Silodosin—Immune system disorder—Epirubicin—uterine cancer	0.000509	0.00253	CcSEcCtD
Silodosin—Mediastinal disorder—Epirubicin—uterine cancer	0.000508	0.00253	CcSEcCtD
Silodosin—Pruritus—Etoposide—uterine cancer	0.000505	0.00251	CcSEcCtD
Silodosin—Mental disorder—Epirubicin—uterine cancer	0.000493	0.00246	CcSEcCtD
Silodosin—Diarrhoea—Etoposide—uterine cancer	0.000488	0.00243	CcSEcCtD
Silodosin—Cardiac disorder—Doxorubicin—uterine cancer	0.000484	0.00241	CcSEcCtD
Silodosin—Angiopathy—Doxorubicin—uterine cancer	0.000473	0.00235	CcSEcCtD
Silodosin—Dizziness—Etoposide—uterine cancer	0.000472	0.00235	CcSEcCtD
Silodosin—Immune system disorder—Doxorubicin—uterine cancer	0.000471	0.00234	CcSEcCtD
Silodosin—Mediastinal disorder—Doxorubicin—uterine cancer	0.00047	0.00234	CcSEcCtD
Silodosin—Mental disorder—Doxorubicin—uterine cancer	0.000457	0.00227	CcSEcCtD
Silodosin—Rash—Etoposide—uterine cancer	0.00045	0.00224	CcSEcCtD
Silodosin—Dermatitis—Etoposide—uterine cancer	0.00045	0.00224	CcSEcCtD
Silodosin—Headache—Etoposide—uterine cancer	0.000447	0.00223	CcSEcCtD
Silodosin—Syncope—Epirubicin—uterine cancer	0.00044	0.00219	CcSEcCtD
Silodosin—Palpitations—Epirubicin—uterine cancer	0.000433	0.00216	CcSEcCtD
Silodosin—Loss of consciousness—Epirubicin—uterine cancer	0.000431	0.00215	CcSEcCtD
Silodosin—Nausea—Etoposide—uterine cancer	0.000424	0.00211	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000414	0.00206	CcSEcCtD
Silodosin—ADRA1D—female reproductive system—uterine cancer	0.000413	0.0635	CbGeAlD
Silodosin—Dry mouth—Epirubicin—uterine cancer	0.000408	0.00203	CcSEcCtD
Silodosin—Syncope—Doxorubicin—uterine cancer	0.000407	0.00203	CcSEcCtD
Silodosin—Palpitations—Doxorubicin—uterine cancer	0.000401	0.002	CcSEcCtD
Silodosin—Loss of consciousness—Doxorubicin—uterine cancer	0.000399	0.00199	CcSEcCtD
Silodosin—Shock—Epirubicin—uterine cancer	0.000394	0.00196	CcSEcCtD
Silodosin—Nervous system disorder—Epirubicin—uterine cancer	0.000392	0.00195	CcSEcCtD
Silodosin—Tachycardia—Epirubicin—uterine cancer	0.00039	0.00194	CcSEcCtD
Silodosin—Skin disorder—Epirubicin—uterine cancer	0.000389	0.00194	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000384	0.00191	CcSEcCtD
Silodosin—Dry mouth—Doxorubicin—uterine cancer	0.000378	0.00188	CcSEcCtD
Silodosin—Hypotension—Epirubicin—uterine cancer	0.000374	0.00186	CcSEcCtD
Silodosin—Shock—Doxorubicin—uterine cancer	0.000364	0.00181	CcSEcCtD
Silodosin—Nervous system disorder—Doxorubicin—uterine cancer	0.000363	0.00181	CcSEcCtD
Silodosin—Insomnia—Epirubicin—uterine cancer	0.000362	0.0018	CcSEcCtD
Silodosin—Tachycardia—Doxorubicin—uterine cancer	0.000361	0.0018	CcSEcCtD
Silodosin—Skin disorder—Doxorubicin—uterine cancer	0.00036	0.00179	CcSEcCtD
Silodosin—Hypotension—Doxorubicin—uterine cancer	0.000346	0.00172	CcSEcCtD
Silodosin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000345	0.00172	CcSEcCtD
Silodosin—Insomnia—Doxorubicin—uterine cancer	0.000335	0.00167	CcSEcCtD
Silodosin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000327	0.00163	CcSEcCtD
Silodosin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.00032	0.00159	CcSEcCtD
Silodosin—ADRA1A—epithelium—uterine cancer	0.00032	0.0491	CbGeAlD
Silodosin—Urticaria—Epirubicin—uterine cancer	0.000318	0.00158	CcSEcCtD
Silodosin—Abdominal pain—Epirubicin—uterine cancer	0.000316	0.00158	CcSEcCtD
Silodosin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000303	0.00151	CcSEcCtD
Silodosin—ADRA1A—renal system—uterine cancer	0.000296	0.0455	CbGeAlD
Silodosin—Urticaria—Doxorubicin—uterine cancer	0.000294	0.00146	CcSEcCtD
Silodosin—Abdominal pain—Doxorubicin—uterine cancer	0.000293	0.00146	CcSEcCtD
Silodosin—Asthenia—Epirubicin—uterine cancer	0.000287	0.00143	CcSEcCtD
Silodosin—Pruritus—Epirubicin—uterine cancer	0.000283	0.00141	CcSEcCtD
Silodosin—Diarrhoea—Epirubicin—uterine cancer	0.000274	0.00136	CcSEcCtD
Silodosin—Asthenia—Doxorubicin—uterine cancer	0.000266	0.00132	CcSEcCtD
Silodosin—Dizziness—Epirubicin—uterine cancer	0.000265	0.00132	CcSEcCtD
Silodosin—Pruritus—Doxorubicin—uterine cancer	0.000262	0.0013	CcSEcCtD
Silodosin—Diarrhoea—Doxorubicin—uterine cancer	0.000253	0.00126	CcSEcCtD
Silodosin—Rash—Epirubicin—uterine cancer	0.000252	0.00126	CcSEcCtD
Silodosin—Dermatitis—Epirubicin—uterine cancer	0.000252	0.00126	CcSEcCtD
Silodosin—Headache—Epirubicin—uterine cancer	0.000251	0.00125	CcSEcCtD
Silodosin—Dizziness—Doxorubicin—uterine cancer	0.000245	0.00122	CcSEcCtD
Silodosin—Nausea—Epirubicin—uterine cancer	0.000238	0.00118	CcSEcCtD
Silodosin—Rash—Doxorubicin—uterine cancer	0.000233	0.00116	CcSEcCtD
Silodosin—Dermatitis—Doxorubicin—uterine cancer	0.000233	0.00116	CcSEcCtD
Silodosin—Headache—Doxorubicin—uterine cancer	0.000232	0.00115	CcSEcCtD
Silodosin—Nausea—Doxorubicin—uterine cancer	0.00022	0.0011	CcSEcCtD
Silodosin—CYP3A4—renal system—uterine cancer	0.000177	0.0273	CbGeAlD
Silodosin—ABCB1—myometrium—uterine cancer	0.000173	0.0265	CbGeAlD
Silodosin—CYP3A4—female reproductive system—uterine cancer	0.000142	0.0218	CbGeAlD
Silodosin—ABCB1—epithelium—uterine cancer	0.000135	0.0208	CbGeAlD
Silodosin—ABCB1—uterine cervix—uterine cancer	0.000134	0.0206	CbGeAlD
Silodosin—ABCB1—decidua—uterine cancer	0.000128	0.0196	CbGeAlD
Silodosin—ABCB1—renal system—uterine cancer	0.000126	0.0193	CbGeAlD
Silodosin—ABCB1—endometrium—uterine cancer	0.000121	0.0187	CbGeAlD
Silodosin—ABCB1—mammalian vulva—uterine cancer	0.000117	0.018	CbGeAlD
Silodosin—ABCB1—uterus—uterine cancer	0.000112	0.0172	CbGeAlD
Silodosin—ABCB1—female reproductive system—uterine cancer	0.000101	0.0155	CbGeAlD
Silodosin—ABCB1—female gonad—uterine cancer	9.15e-05	0.0141	CbGeAlD
Silodosin—ABCB1—vagina—uterine cancer	9.1e-05	0.014	CbGeAlD
Silodosin—ABCB1—lymph node—uterine cancer	5.88e-05	0.00904	CbGeAlD
